Journal
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
Volume 134, Issue 18, Pages 949-954Publisher
GEORG THIEME VERLAG KG
DOI: 10.1055/s-0029-1220255
Keywords
type 2 diabetes; pioglitazone; rosiglitazone; oral antidiabetic drugs; insulin; evidence; cardiovascular risk; comorbidities
Categories
Ask authors/readers for more resources
Share Paper
